GB Sciences Names Five New Members to Scientific Advisory Board

GrowBLOX Sciences, Inc., “GB Sciences” (GBLX), a cannabinoid therapy research and development firm, has released the names of five doctors joining its scientific advisory board. Chaired by GB Sciences’ Chief Science Officer Andrea Small-Howard, PhD, MBA, new board members include: John Abroon, MD; Alfredo L. Axtmayer,... more →
Posted in: Press

With Strategic Investor, Private Placement Closed By Maple Leaf

This agency agreement will allow AGL to assist Maple Leaf, on a best effort basis when determined by Maple Leaf, to raise up to Cdn$5 million outside North America for the Company to pursue its medical marijuana business.This agreement is for the period of 1 year from September 1, 2014. AGL is a capital holding company registered... more →
Posted in: Investing

Greengro Technologies “Globe Farmacy Arizona” Project Update

Greengro Technologies (PINKSHEETS: GRNH) announced today that it has received the greenlight to proceed with first phase build-out of Globe Farmacy Arizona’s facility. The deal, previously announced, was delayed due to ownership issues of the underlying property. According to Greengro’s James Haas, “This deal is... more →
Posted in: Press

Medbox Secures Additional Capital from Current Lender

Medbox, Inc., (MDBX), the leading licensing, infrastructure and security specialist, patented technology provider, and partner to the cannabis industry, is pleased to announce that it has secured an additional $0.5 million in capital from a current lender.  The additional financing closed on Friday, September 26, 2014. The remaining... more →
Posted in: Press

Marijuana Legalization Brings Potential Increase in Tax Dollars

On November 4, several states, at least 17 municipalities, and one U.S. territory will vote on drug policy reform. The legalization of marijuana will result in a significant increase in tax revenue amounting to millions of dollars. Studies show that when states such as Alaska, Florida, Oregon, and Washington, D.C. are combined,... more →
Posted in: News

Abattis Announces Appointment Guy Dancosse, Q.C. to Board of Directors

Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (ATTBF) (CSE:ATT), a specialty biotechnology company focused on cultivating, licensing, and marketing proprietary ingredients, bio-similar compounds, equipment, and consulting services to North American medicinal markets, today announced that Guy Dancosse,... more →
Posted in: Press

Concert Pharmaceuticals Announces Positive CTP-354 Data

Investors in the pharma/biotech sector eagerly wait for pipeline updates as they play an important role in deciding whether or not to invest in a particular company. These updates provide information on experimental drugs and at times give an insight on the commercial potential of the candidate once it is successfully developed and... more →
Posted in: Press

Shareholder Report Of Cannamed For 2014 2nd Quarter

Our service contracts initiate revenues to CannaMed this quarter. Future Financings: New 506(c) Private Placement up to $10,000,000 We are now beginning a new private offering under Rule 506(c) of Regulation D whereby we intend to raise up to an additional $10,000,000. We intend to use the net proceeds from this offering to support... more →
Posted in: Investing

Health & Wellness Industry Gets Excited By Recent Federal Medical Marijuana Ruling

(NASDAQ: HQY ) was recently welcomed to the NASDAQ Stock Market. Founded in 2002, HealthEquity is a leader and an innovator in the high growth category of technology-enabled services platforms that empower consumers to make healthcare saving and spending decisions. The Company’s innovative technology platform and tax-advantaged... more →
Posted in: Investing
1 298 299 300 301 302 339